GET THE APP

..

Journal of Bioanalysis & Biomedicine

ISSN: 1948-593X

Open Access

Development of a Rapid Point-of-Care Diagnostic Test for Zika Virus Infection Based on CRISPR-Cas12a Technology

Abstract

Coralie Reimerink*

The outbreak of Zika virus has posed significant global health challenges, necessitating the development of rapid and accurate diagnostic tools. This study presents the development of a point-of-care diagnostic test for Zika virus infection utilizing CRISPR-Cas12a technology. Leveraging the specific and robust targeting capability of CRISPR-Cas12a, we designed a diagnostic platform capable of detecting ZIKV with high sensitivity and specificity. The assay demonstrated a limit of detection comparable to existing laboratory-based methods but with the advantage of faster results and minimal equipment requirements. This CRISPR-Cas12a-based diagnostic test offers a promising solution for timely and effective ZIKV detection, especially in resource-limited settings.

HTML PDF

Share this article

Google Scholar citation report
Citations: 3099

Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report

Journal of Bioanalysis & Biomedicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward
https://www.olimpbase.org/1937/